glp 1 study compares GLP-1 drug benefits and finds substantial variation in clinical effects GLP-1 receptor agonists | How

The weight loss potential for each patient can vary

This is especially relevant for RA patients who arent significantly overweight but still have metabolic inflammation insulin resistance, prediabetes, or a stubbornly elevated CRP despite adequate drug doses

Beyond medication, Found reinforces long-term success with coaching, habit tracking, app-based tools to address emotional eating, and a built-in community where members support each other along the way

How does the gut microbiome influence metabolic health

doi: 10.1016/j.clnesp.2022.01.014

Clinical Evidence on Bone Density Studies evaluating the relationship between GLP1 therapy and bone outcomes have yielded mixed results